Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: Evidence for blockade of apoptosis at a distal signalling step

Immunology

Volumn 91, Issue 4, 1997, Pages 586-593

  Macfarlane, D E ^a   Manzel, L ^a   Krieg, A M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; IMMUNOGLOBULIN M; OLIGODEOXYNUCLEOTIDE; PROTEIN KINASE C;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL LINE; IMMUNOMODULATION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030812046     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00301.x     Document Type: Article

References (32)

1. MESSINA J., GILKESON G. & PISETSKY D. (1991) Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 147, 1759.
2. YAMAMOTO S., YAMAMOTO T., SHIMADA S. et al. (1992) DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 36, 983.
3. KRIEG A., YI A.-K., MATSON S. et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546.
4. KRIEG A. (1996) Lymphocyte activation by CpG dinucleotide motifs. Trends Microbiol 4, 73.
5. KLINMAN D., YI A.-K., BEAUCAGE S., CONOVER J. & KRIEG A. (1996) CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and INF-gamma. Proc Natl Acad Sci USA, 93, 2879.
6. YI A.-K., HORNBECK P., LAFRENZ D. & KRIEG A. (1996) CpG DNA rescue of murine B lymphoma cells from anti-IgM induced growth arrest and programmed cell death is associated with expression of c-myc, bcl-XL. J Immunol 157, 4918.
7. BOYD A. & SCHRADER J. (1981) The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. J Immunol 126, 2466.
8. SCOTT D., TUTTLE J., LIVNAT D., HAYES W., COGSWELL J. & KENG P. (1985) Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection of properties of resistant mutants. Cell Immunol 93, 124.
9. BECKWITH M., FENTON R., KATONA I. & LONGO D. (1996) Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line. Blood 87, 202.
10. GORDON J. (1995) CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. [Review]. Blood Rev 9, 53.
11. STELLAR H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445.
12. ENARI M., HUG H. & NAGATA S. (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78.
13. JARVIS W., KOLESNICK R.N., FORNARI F., TRAYLOR R., GERWITZ D. & GRANT S. (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91, 73.
14. HUNAN Y. (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269, 3125.
15. COHEN J. & DUKE R. (1984) Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Biol Chem 132, 38.
16. MCCONKEY D., HARTZELL P., JONDAL M. & SORRENIUS S. (1989) Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem 264, 13 399.
17. XIA Z., DICKENS M., RAINGEAUD J., DAVIS R. & GREENBERG M. (1995) Opposing effects of ERK and JNK-p38 kinases on apoptosis. Science 270, 1326.
18. ILLERA V., PERANDONES C., STUNZ L., MOWER D. & ASHMAN R. (1993) Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol 151, 2965.
19. GHOSH T., BIAN J., SHORT A., RYBAK S. & GILL D. (1991) Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth. J Biol Chem 266, 24 690.
20. 2+ signals activate apoptosis in thymocytes: studies using the Ca(2+)-ATPase inhibitor thapsigargin. Exp Cell Res 212, 84.
21. CHOI M.S., BOISE L.H., GOTTSCHALK A.R., QUINTANS J., THOMPSON C.B. & KLAUS G.G. (1995) The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Europ J Immunol 25, 1352.
22. HOCKENBERY D.M., OLTVAI Z.N., YIN X.M., MILLIMAN C.L. & KORSMEYER S.J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241.
23. WRIGHT S.C., ZHENG H., ZHONG J., TORTI F.M. & LARRICK J.W. (1993) Role of protein phosphorylation in TNE-induced apoptosis: phosphatase inhibitors synergize with TNE to activate DNA fragmentation in normal as well as TNF-resistant U937 variants. J Cell Biochem 53, 222.
24. WYLLIE A., MORRIS R., SMITH A. & DUNLOP D. (1984) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142, 67.
25. RAJEWSKY K. (1996) Clonal selection and learning in the antibody system. Nature 381, 751.
26. KEHRY M. (1996) CD40-mediated signaling in B cells. Balancing cell survival, growth and death. J Immunol 156, 2345.
27. PARRY S., HASBOLD J., HOLMAN M. & KLAUS G. (1994) Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 or anti-CD40. J Immunol 152, 2821.
28. FEARSON D. & LOCKSLEY R. (1996) The instructive role of innate immunity in the acquired immune response. Science 272, 50.
29. FANG W., RIVARD J., GANSER J. et al. (1995) Bcl-xl rescues WEHI 231 B lymphocytes from oxidant-mediated death following apoptotic stimuli. J Immunol 155, 66.
30. SUN X.M. & COHEN G.M. (1994) Mg(2+)-dependent cleavage of DNA into kilobase pair fragments is responsible for the initial degradation of DNA in apoptosis. J Biol Chem 269, 14 857.
31. WALKER P.R., WEAVER V.M., LACH B., LEBLANC J. & SIKORSKA M. (1994) Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp Cell Res 213, 100.
32. GOTTSCHALK A., MCSHAN C., KILKUS J., DAWSON G. & QUINTANS J. (1995) Resistance to anti-IgM-induced apoptosis in a WEHI-231 subline is due to insufficient production of ceramide. Eur J Immunol 25, 1032.